• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织型纤溶酶原激活剂在脑栓塞模型中的溶栓作用。

Thrombolytic effect of tissue plasminogen activator in a cerebral embolic model.

作者信息

Kimata H, Nakajima K, Suzuki H, Koide T, Narita T

机构信息

Tokyo Research Laboratories, Kowa Co., Ltd., Japan.

出版信息

J Pharmacobiodyn. 1991 Jul;14(7):399-406. doi: 10.1248/bpb1978.14.399.

DOI:10.1248/bpb1978.14.399
PMID:1802987
Abstract

An experimental cerebral embolic model was prepared by an injection of [125I]fibrin clot particles (20-100 microns) into the left internal carotid artery in rats, and the changes in radioactivity of the brain were continuously monitored by a gamma-ray detector. The autoradiograms of the caput transections showed the existence of emboli in small vessels of the left hemicerebrum. After the injection of [125I]fibrin clots, the radioactivity spontaneously decreased to a half of the initial radioactivity at 90 min. The decrease in radioactivity which represented the embolus dissolution was markedly suppressed by an antiplasmin agent, trans-4-aminomethyl cyclohexane carboxylic acid, indicating that the endogenous fibrinolysis through the activation of plasminogen is generated in the cerebral small vessels after the embolization. Consecutive injection of fibrin clots caused a summation of the radioactivity and decreased the rate of dissolution at every embolus preparation. The thrombolytic agents were infused via the left internal carotid artery for 30 min after the second successive injection of fibrin clots. Although the spontaneous dissolution of emboli was observed during the infusion of saline, tissue plasminogen activator (t-PA) as well as urokinase plasminogen activator (u-PA) produced a further dissolution. Approximately half of the emboli disappeared 60 min after the infusion of t-PA at a dose of 75 micrograms/kg and at a dose of 10000 IU/kg, respectively.

摘要

通过向大鼠左颈内动脉注射[125I]纤维蛋白凝块颗粒(20 - 100微米)制备实验性脑栓塞模型,并用γ射线探测器连续监测脑部放射性变化。脑横断面的放射自显影片显示左半脑小血管中有栓子存在。注射[125I]纤维蛋白凝块后,放射性在90分钟时自发降至初始放射性的一半。代表栓子溶解的放射性下降被抗纤溶药物反式-4-氨甲基环己烷羧酸显著抑制,这表明栓塞后在脑小血管中通过纤溶酶原激活产生了内源性纤维蛋白溶解。连续注射纤维蛋白凝块导致放射性累加,并降低每次栓子形成时的溶解速率。在第二次连续注射纤维蛋白凝块后,通过左颈内动脉输注溶栓药物30分钟。尽管在输注生理盐水期间观察到栓子的自发溶解,但组织型纤溶酶原激活剂(t-PA)以及尿激酶型纤溶酶原激活剂(u-PA)都进一步促进了溶解。分别以75微克/千克和10000国际单位/千克的剂量输注t-PA后60分钟,约一半的栓子消失。

相似文献

1
Thrombolytic effect of tissue plasminogen activator in a cerebral embolic model.组织型纤溶酶原激活剂在脑栓塞模型中的溶栓作用。
J Pharmacobiodyn. 1991 Jul;14(7):399-406. doi: 10.1248/bpb1978.14.399.
2
Fibrinolytic effect of tissue plasminogen activator on cerebral embolism in stroke-prone spontaneously hypertensive rats.组织型纤溶酶原激活剂对易卒中自发性高血压大鼠脑栓塞的纤溶作用
Chem Pharm Bull (Tokyo). 1991 Dec;39(12):3327-30. doi: 10.1248/cpb.39.3327.
3
Dissolution of emboli in rats with experimental cerebral thromboembolism by recombinant human tissue plasminogen activator (TD-2061).
Thromb Res. 1990 Aug 15;59(4):703-12. doi: 10.1016/0049-3848(90)90052-e.
4
Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.在犬动静脉联合血栓形成模型中组织型纤溶酶原激活剂(t-PA)、单链尿激酶型纤溶酶原激活剂(u-PA)和K1K2Pu(一种t-PA/u-PA嵌合体)的溶栓特性比较
J Am Coll Cardiol. 1992 May;19(6):1350-9. doi: 10.1016/0735-1097(92)90344-m.
5
Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke.在兔栓塞性中风模型中使用组织型纤溶酶原激活剂对脑血凝块进行优化溶栓。
J Pharmacol Exp Ther. 1993 Jan;264(1):67-73.
6
Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected].动脉内注射组织型纤溶酶原激活剂和尿激酶对兔脑循环中自体动脉栓子的影响[校正后]
Stroke. 1990 Nov;21(11):1594-9. doi: 10.1161/01.str.21.11.1594.
7
Additive fibrinolysis by recombinant tissue-type plasminogen activator (r-t-PA) and recombinant single-chain urokinase type plasminogen activator (r-scu-PA) in rabbit pulmonary thrombosis.重组组织型纤溶酶原激活剂(r-t-PA)与重组单链尿激酶型纤溶酶原激活剂(r-scu-PA)对兔肺血栓形成的协同纤溶作用
Thromb Res. 1989 Oct 1;56(1):59-65. doi: 10.1016/0049-3848(89)90008-x.
8
Localization of tissue plasminogen activator on experimental microthrombi in rats. Microautoradiographic observations.组织型纤溶酶原激活物在大鼠实验性微血栓上的定位。显微放射自显影观察。
J Pharmacobiodyn. 1991 Jan;14(1):25-33. doi: 10.1248/bpb1978.14.25.
9
A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding.在兔栓塞性中风和外周出血模型中组织型纤溶酶原激活剂的长半衰期和纤维蛋白特异性形式
Stroke. 1994 Oct;25(10):2072-8; discussion 2078-9. doi: 10.1161/01.str.25.10.2072.
10
[An experimental study of local fibrinolysis using tissue plasminogen activator and urokinase in a canine common carotid artery thrombus model].[在犬颈总动脉血栓模型中使用组织型纤溶酶原激活剂和尿激酶进行局部纤溶的实验研究]
No To Shinkei. 1990 Feb;42(2):193-201.